213 related articles for article (PubMed ID: 27957789)
21. Retrospective study of Dana Farber Consortium Protocol in newly diagnosed Egyptian adolescents and young adults with acute lymphoblastic leukemia: Tanta experience.
Elashtokhy HEA; Elgohary HE; Eldeep BB; Gaber SM; Elbedewy TA
J Egypt Natl Canc Inst; 2021 Apr; 33(1):9. PubMed ID: 33826046
[TBL] [Abstract][Full Text] [Related]
22. Treating Adult Acute Lymphoblastic Leukemia in Brazil-Increased Early Mortality Using a German Multicenter Acute Lymphoblastic Leukemia-based regimen.
Fernandes da Silva Junior W; Medina AB; Yamakawa PE; Buccheri V; Velloso EDRP; Rocha V
Clin Lymphoma Myeloma Leuk; 2018 Jun; 18(6):e255-e259. PubMed ID: 29605423
[TBL] [Abstract][Full Text] [Related]
23. Comparison of the results of the treatment of adolescents and young adults with standard-risk acute lymphoblastic leukemia with the Programa Español de Tratamiento en Hematología pediatric-based protocol ALL-96.
Ribera JM; Oriol A; Sanz MA; Tormo M; Fernández-Abellán P; del Potro E; Abella E; Bueno J; Parody R; Bastida P; Grande C; Heras I; Bethencourt C; Feliu E; Ortega JJ
J Clin Oncol; 2008 Apr; 26(11):1843-9. PubMed ID: 18398150
[TBL] [Abstract][Full Text] [Related]
24. Improving outcome of acute lymphoblastic leukemia with a simplified protocol: report from a tertiary care center in north India.
Trehan A; Bansal D; Varma N; Vora A
Pediatr Blood Cancer; 2017 Apr; 64(4):. PubMed ID: 27762058
[TBL] [Abstract][Full Text] [Related]
25. [Clinical effect of CCLG-ALL2008 regimen in treatment of children and adolescents aged >10 years with acute lymphoblastic leukemia].
Lan Y; Chen XJ; Zou Y; Ruan M; Zhu XF
Zhongguo Dang Dai Er Ke Za Zhi; 2019 May; 21(5):405-410. PubMed ID: 31104652
[TBL] [Abstract][Full Text] [Related]
26. Improved survival of children with isolated CNS relapse of acute lymphoblastic leukemia: a pediatric oncology group study .
Ritchey AK; Pollock BH; Lauer SJ; Andejeski Y; Barredo J; Buchanan GR
J Clin Oncol; 1999 Dec; 17(12):3745-52. PubMed ID: 10577846
[TBL] [Abstract][Full Text] [Related]
27. Survival outcome following isolated central nervous system relapse treated with additional chemotherapy and craniospinal irradiation in childhood acute lymphoblastic leukemia.
Kumar P; Kun LE; Hustu HO; Mulhern RK; Hancock ML; Coffey D; Rivera GK
Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):477-83. PubMed ID: 7852109
[TBL] [Abstract][Full Text] [Related]
28. Outcome of acute lymphoblastic leukemia treatment using national protocols at the Queen Sirikit National Institute of Child Health.
Kanjanapongkul S
J Med Assoc Thai; 2014 Jun; 97 Suppl 6():S1-5. PubMed ID: 25391165
[TBL] [Abstract][Full Text] [Related]
29. Adolescents and young adults with acute lymphoblastic leukemia have a better outcome when treated with pediatric-inspired regimens: systematic review and meta-analysis.
Ram R; Wolach O; Vidal L; Gafter-Gvili A; Shpilberg O; Raanani P
Am J Hematol; 2012 May; 87(5):472-8. PubMed ID: 22388572
[TBL] [Abstract][Full Text] [Related]
30. [Evaluation of the efficacy of two successive protocols on pediatric acute lymphoblastic leukemia with E2A-PBX1 fusion gene].
Mei YY; Gao C; Cui L; Zhao XX; Zhao W; Li WJ; Wang KL; Jiang J; Zhang RD; Xie J; Shi HW; Wang B; Zhang YH; Ma XL; Zhou X; Wu MY; Li ZG
Zhonghua Er Ke Za Zhi; 2013 Jun; 51(6):467-71. PubMed ID: 24120066
[TBL] [Abstract][Full Text] [Related]
31. Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial.
Ribera JM; Ortega JJ; Oriol A; Granada I; Hernández-Rivas JM; Parody R; Bethencourt C; Rivas C; Bastida P; del Potro E; González-Valentín ME; Moreno MJ; Besalduch J; Fernández-Calvo J; Tormo M; Arias J; Molinés A; Sanz MA; Maldonado J; Millá F; Feliu E; San Miguel JF;
Haematologica; 2002 Feb; 87(2):154-66. PubMed ID: 11836166
[TBL] [Abstract][Full Text] [Related]
32. [Treatment results in children with the standard risk acute lymphoblastic leukemia treated with high dose of methotrexate (5.0 g/m2). 11 years of the Polish Pediatric Leukemia/Lymphoma Study Group experience].
Derwich K; Wachowiaki J; Kaczmarek-Kanoldi M; Balcerska A; Balwierz W; Chybicka A; Kowalczyk JR; Matysiak M; Jackowska T; Sońta-Jakimczyk D; Wysocki M; Chełmecka-Hanuszewicz L; Cwiklińska M; Kołtan A; Malinowska I; Odój T; Płoszyńska A; Steczowicz M; Wojciechowska V; Wójtowicz A;
Przegl Lek; 2006; 63(1):7-10. PubMed ID: 16892891
[TBL] [Abstract][Full Text] [Related]
33. ALL-BFM 95 treatment in Turkish children with acute lymphoblastic leukemia--experience of a single center.
Kocak U; Gursel T; Kaya Z; Aral YZ; Albayrak M; Keskin EY; Belen B; Isık M; Oner N
Pediatr Hematol Oncol; 2012 Mar; 29(2):130-40. PubMed ID: 22376016
[TBL] [Abstract][Full Text] [Related]
34. Effective VCR/DEX pulse maintenance therapy in the KYCCSG ALL-02 protocol for pediatric acute lymphoblastic leukemia.
Okamoto Y; Koga Y; Inagaki J; Ozono S; Ueda K; Shimoura M; Itonaga N; Shinkoda Y; Moritake H; Nomura Y; Nakayama H; Hotta N; Hidaka Y; Shimonodan H; Suga N; Tanabe T; Nakashima K; Fukano R; Kawano Y
Int J Hematol; 2016 Feb; 103(2):202-9. PubMed ID: 26586463
[TBL] [Abstract][Full Text] [Related]
35. Clinical Predictors and Prognostic Model for Pediatric Lymphoblastic Lymphoma Treated With Uniform BFM90 Protocol: A Single-Center Experience of 65 Patients From Asia.
Patel A; Tiwari A; Biswas B; Chand Sharma M; Vishnubhatla S; Bakhshi S
Clin Lymphoma Myeloma Leuk; 2019 Jun; 19(6):e291-e298. PubMed ID: 30905539
[TBL] [Abstract][Full Text] [Related]
36. [Clinical features and prognosis of children with lymphoblastic lymphoma].
Jin L; Zhang R; Huang S; Yang J; Duan YL; Zhang YH
Zhonghua Zhong Liu Za Zhi; 2012 Feb; 34(2):138-42. PubMed ID: 22780934
[TBL] [Abstract][Full Text] [Related]
37. [Treatment failure in children with acute myelocytic leukemia: over 25-year experience of Polish Pediatric Leukemia/Lymphoma Study Group with four consecutive unified treatment protocols for childhood acute myelocytic leukemia].
Dłuzniewska A; Balwierz W; Balcerska A; Chybicka A; Kamieńska E; Karolczyk G; Karpińska-Derda I; Krawczuk-Rybak M; Kowalczyk JR; Lewandowska D; Maciejka-Kapuścińska L; Kołtano S; Malinowska I; Matysiak M; Mikołajczyk M; Mizia-Malarz A; Muszyńska-Rosłan K; Niedźwiedzki M; Pohorecka J; Sikorska-Fic B; Sobol G; Sońta-Jakimczyk D; Tomaszewska R; Urasiński T; Wachowiak J; Wieczorek M; Wójcik B; Wysocki M
Przegl Lek; 2010; 67(6):366-70. PubMed ID: 21344763
[TBL] [Abstract][Full Text] [Related]
38. Treatment outcome of pediatric acute lymphoblastic leukemia in Yeungnam region: Multicenter retrospective study of Study Alliance of Yeungnam Pediatric Hematology-Oncology (SAYPH).
Yang EJ; Park KM; Lee JM; Hah JO; Park SK; Suh JK; Kim JY; Lee KS; Park J; Park ES; Lim J; Shim YJ; Kim HS; Kong SG; Chueh H; Choi EJ; Park JA; Lim YT
Pediatr Hematol Oncol; 2018 May; 35(4):276-287. PubMed ID: 30633619
[TBL] [Abstract][Full Text] [Related]
39. Liposomal daunorubicin, fludarabine, and cytarabine (FLAD) as bridge therapy to stem cell transplant in relapsed and refractory acute leukemia.
De Astis E; Clavio M; Raiola AM; Ghiso A; Guolo F; Minetto P; Galaverna F; Miglino M; Di Grazia C; Ballerini F; Marani C; Pastori G; Mitscheunig L; Cruciani F; Lovera D; Varaldo R; Ghiggi C; Lemoli RM; Bacigalupo A; Gobbi M
Ann Hematol; 2014 Dec; 93(12):2011-8. PubMed ID: 24989345
[TBL] [Abstract][Full Text] [Related]
40. Should adolescents with acute lymphoblastic leukemia be treated as old children or young adults? Comparison of the French FRALLE-93 and LALA-94 trials.
Boissel N; Auclerc MF; Lhéritier V; Perel Y; Thomas X; Leblanc T; Rousselot P; Cayuela JM; Gabert J; Fegueux N; Piguet C; Huguet-Rigal F; Berthou C; Boiron JM; Pautas C; Michel G; Fière D; Leverger G; Dombret H; Baruchel A
J Clin Oncol; 2003 Mar; 21(5):774-80. PubMed ID: 12610173
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
